C
hlamydiae are important human pathogens due to the wide repertoire of important diseases that they cause (1) (2) (3) (4) (5) . These microorganisms infect primary epithelial cells with subsequent attraction of monocytes/macrophages (6, 7) . They frequently cause chronic inflammatory diseases characterized by the presence of a high number of mononuclear cells (8) that are involved in the pathogenesis by inducing mediators of inflammation. However, few data have been published about chlamydiae components involved in inflammatory response, and results are still debated. Chlamydial LPS (9, 10) and heat shock protein (hsp) 3 60 (11, 12) were involved in some reports but not in others (13) (14) (15) . In signaling pathway, whole bacteria or Chlamydia hsp60 have been shown to induce TLR-mediated activation, but the signaling receptor differed among studies from both TLR2 and TLR4 (16) , only TLR4 (17, 18) , only TLR2 (14) , to largely TLR2 and to a minor extent TLR4 (19) . Except LPS and hsp60, chlamydiae components responsible for these effects were unidentified.
To identify chlamydial component(s) able to induce production of proinflammatory cytokines by human monocytes/macrophages, inactivated elementary bodies (EB), one of the two forms presented by chlamydiae in their biphasic developmental cycle, as well as seven individual chlamydial Ags: purified LPS, recombinant hsp70 (rhsp70), rhsp60, rhsp10, recombinant polypeptide encoded by open reading frame 3 of the plasmid (rpgp3), recombinant macrophage infectivity potentiator (rMip), and recombinant outer membrane protein 2 (rOmp2) were carefully purified and tested. Aside from EB, rMip displayed the highest proinflammatory activity, stimulating the synthesis of IL-1␤, TNF-␣, IL-6, and IL-8. Mip was recently shown to have lipid modification similar to that of other procaryotic lipoproteins and to be exposed at the surface of EB (20) . The proinflammatory activity of EB was significantly attenuated in the presence of polyclonal Ab to rMip. Failure of stimulation with a nonlipidated C20A rMip variant as well as after lipase treatment of rMip showed that the proinflammatory activity was dependent upon lipid modification. Use of blocking mAb and human embryonic kidney (HEK)-293 transfected cells revealed that TLR2/TLR1/TLR6 and CD14 but not TLR4 were involved in mediating these effects.
Materials and Methods

Bacteria and Ags
EB of Chlamydia trachomatis
LGV2 strain 434 (inactivated by a photochemical treatment affecting bacterial genomes) were either purchased from Biodesign International (Milan Analytica) or prepared according to the method of Boleti et al. (21) . Chlamydia LPS was extracted according to Rund et al. (22) . LPS from Escherichia coli serotype O55:B5 and Salmonella typhimurium were purchased from Sigma-Aldrich (Fluka Chemie) and repurified (23) to rule out protein and lipoprotein contamination. Cloning, expression in E. coli, and purification of six different recombinant proteins from C. trachomatis (rhsp70, rhsp60, rhsp10, rpgp3, rMip, and rOmp2) were previously described (24, 25) . To rule out LPS and LPSassociated molecule contamination (26 -28) , all recombinant proteins were subsequently treated by polymyxin B-agarose (Sigma-Aldrich) and had Ͻ10 endotoxin units per milligram, according to the Limulus Amoebocyte Lysate chromogenic assay (BioWhittaker Cambrex), which is an amount that did not stimulate proinflammatory cytokine production by itself. Preparations of native Mip and C20A rMip variant were previously described (20) . Protein concentrations were determined by using a microbicinchoninic acid protein assay kit (Pierce, Perbio Science). Racemic Pam 3 CSK 4 (Pam 3 -Cys-Ser-Lys 4 -OH) and Pam 2 CSK 4 (Pam 2 -Cys-Ser-Lys 4 -OH) used as synthetic triacylated and diacylated control lipopeptides, respectively, were obtained from EMC Microcollections.
Abs and antiserum preparation
Anti-CD14 (clone MY4, IgG2b) was purchased from Coulter Clone (Beckman Coulter), anti-TLR1 (clone GD2.F4, IgG1) from Hycult Biotechnology (Biocoba), anti-TLR2 and anti-TLR4 (clone TL2.1 and HTA125, respectively, IgG2a) from ImmunoKontact (AMS Biotechnology). Anti-TLR6 (clone 127, IgG1) was previously described (29) . Isotype-matched mouse IgG1 control was purchased from Southern Biotechnology Associates and IgG2a, and IgG2b from Coulter Clone. Preparation of IgG fraction from rMip antiserum was previously described (20) .
Human monocyte/macrophage culture
PBMC from healthy blood donors were isolated by density gradient centrifugation with Ficoll-Hypaque (Amersham Biosciences). Monocytes/ macrophages were separated by aggregation, gradient of FBS (Invitrogen Life Technologies), and rosetting (30, 31) . Monocyte purity consisted of Ն90% CD14 ϩ cells, Յ1% CD3 ϩ cells, and Յ1% CD19 ϩ cells as assessed by flow cytometry. The enriched monocytes were cultured in 24-well plates (10 5 cells/1 ml per well) in RPMI 1640 containing 2 mM GlutaMAX I, supplemented with 100 U/ml penicillin, 0.1 mg/ml streptomycin, and heatinactivated (30 min at 56°C) endotoxin-free 10% (v/v) FBS (Invitrogen Life Technologies). After 48 h (or indicated time periods) stimulation at 37°C with indicated stimuli, cultures were centrifuged at 400 ϫ g for 10 min at 4°C and cell-free supernatants were collected and stored at Ϫ70°C until cytokine measurements.
THP-1 cell culture
Cells of the human promyelomonocytic cell line THP-1 (32) were purchased from American Type Culture Collection and were grown in RPMI 1640 medium as described above. For monocytic differentiation, they were seeded in 24-well flat-bottom tissue culture plates at a density of 2.5 ϫ 10 5 cells/1 ml per well and allowed to adhere and differentiate 48 h at 37°C in presence of 10 nM PMA (Sigma-Aldrich). After repeated washing with RPMI 1640, PMA-differentiated THP-1 cells were stimulated at 37°C with indicated stimuli. Cell-free supernatants were harvested after 4 h (or indicated time periods) of incubation and kept at Ϫ70°C until cytokine measurements.
Native Mip blocking experiments
PMA-differentiated THP-1 cells were pretreated at 37°C for 1 h with 50 g/ml human IgG to block Fc receptors and prevent subsequent nonspecific binding of IgG and then stimulated with inactivated C. trachomatis EB (5 ϫ 10 6 /ml) in presence of rabbit polyclonal anti-rMip IgG or preimmune IgG (0, 40, or 80 g/ml). Cell-free supernatants were harvested after 4 h of incubation and kept at Ϫ70°C until cytokine measurements.
Heat, proteinase K, alkaline, and lipase treatments of rMip
Heat sensitivity was determined by heating rMip at 100°C for 3 h and proteinase K sensitivity by incubating rMip with 100 g/ml proteinase K (Promega) in 100 mM Tris-HCl (pH 8.0) at 37°C for 2 h, followed by addition of 200 M PMSF. Alkaline hydrolysis was performed according to Muhlradt and Frisch (33) . Briefly, rMip solution was adjusted to pH 13.0 with sodium hydroxide, incubated at 37°C for 1 h, and neutralized with HEPES before assay. Lipase sensitivity was determined with two glycerol ester hydrolases (E.C. 3.1.1.3.) having different side chain specificity (34) . Either 1000 U/ml pig pancreas lipase (type VI-S lipase; Sigma-Aldrich) or 10,000 U/ml Rhizopus arrhizus lipase (type XI lipase; Sigma-Aldrich) were added to rMip at 37°C for 16 h, in 50 mM HEPES buffer (pH 7.5), 10 mM CaCl 2 , followed by heating at 100°C before assay (35) . As controls, rMip was incubated in buffer with no sodium hydroxide or enzymes and PMA-differentiated THP-1 cells were incubated with buffer and enzymes in the absence of rMip. Cell-free supernatants were harvested after 4 h of incubation and kept at Ϫ70°C until cytokine measurements.
CD14, TLR1, TLR2, TLR4, and TLR6 blocking experiments
Blocking experiments were performed after 1 h pretreatment of PMAdifferentiated THP-1 cells with 50 g/ml human IgG to block Fc receptors and prevent subsequent nonspecific binding of blocking Ab or nonimmune isotype controls. Cells were next incubated at 37°C for 1 h with blocking Ab (5 g/ml) before stimulation with either 1 g/ml rMip, inactivated C. trachomatis EB (5 ϫ 10 6 /ml), 0.01 g/ml lipopeptides (Pam 3 CSK 4 or Pam 2 CSK 4 ), or 1 g/ml E. coli LPS. Cell-free supernatants were harvested after 4 h of incubation and kept at Ϫ70°C until cytokine measurements.
Response of TLR/CD14 cell lines
HEK-293 cells stably transfected with either the empty plasmid (293-Null) or human TLR1/2, TLR2/6, or TLR2/CD14 genes were purchased from InvivoGen (LabForce) and maintained in DMEM (Invitrogen Life Technologies) supplemented with 4.5 g/L glucose, 10% FBS, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 10 g/ml blasticidin S (InvivoGen) for 293-Null, 293-hTLR1/2, and 293-hTLR2/6 and with 50 g/ml HygroGold (InvivoGen) for 293-hTLR2/CD14. For stimulation experiments, stable transfected cells were seeded into individual wells of a 48-well tissue culture plate at a concentration of 3 ϫ 10 5 cells in 300 l of complete medium and allowed to adhere overnight. The following day, fresh medium was added, and the cells were stimulated with either 1 g/ml rMip, inactivated C. trachomatis EB (5 ϫ 10 6 /ml), 1 or 0.01 g/ml lipopeptides (Pam 3 CSK 4 or Pam 2 CSK 4 ), or 1 g/ml E. coli LPS for 24 h. Culture supernatants were collected, and IL-8 content was analyzed. Results were expressed in terms of fold increase over the IL-8 levels of unstimulated cells.
Cytokine measurements
Extracellular release of IL-1␤, TNF-␣, IL-6, and IL-8 was determined by a sandwich ELISA technique using the DuoSet ELISA Development Systems (R&D Systems), according to the manufacturer's instructions. The ELISA detection limits were 2 pg/ml for all tested cytokines. When the distributions in cytokine production were not normal, results were expressed as median and interquartile range.
Statistical analysis
Statistical analysis was performed using the SPSS statistical software (for Macintosh, v.10). Kruskal-Wallis and Mann-Whitney U tests were used to compare the levels of inflammatory cytokines produced by human monocytes/macrophages in response to various microbial components. A comparison between two groups was made only when the Kruskal-Wallis test yields statistically significant results. Statistical analysis for PMA-differentiated THP-1 cell and HEK assays were performed using a Student's t test. Differences were considered significant at p Ͻ 0.05.
Results
Inactivated C. trachomatis EB and rMip elicited proinflammatory cytokine production by human monocytes/macrophages and PMA-differentiated THP-1 cells
The pathology of C. trachomatis infection seems to be related to chronic inflammation, characterized by the dominating presence of macrophages in injured tissues. We have therefore tested the ability of inactivated EB and seven chlamydial components (LPS, rhsp70, rhsp60, rhsp10, rpgp3, rMip, and rOmp2) to stimulate the production of various proinflammatory cytokines by healthy blood donor monocytes/macrophages. Inactivated EB as well as rMip induced the release of IL-1␤, TNF-␣, IL-6, and IL-8 in contrast to other chlamydial Ags that did not display any consistent stimulatory effects. Both E. coli and S. typhimurium LPS, used as positive controls, highly induced the release of proinflammatory cytokines, in contrast to chlamydial LPS, as previously reported (10, 15, 36, 37) (Fig. 1) . To further define the ability of rMip to stimulate the synthesis of proinflammatory cytokines, dose-response and time course experiments were performed. A dose-dependent stimulation was observed in presence of increasing concentrations of rMip (0.005-5 g/ml) (Fig. 2) . The release of TNF-␣ was time-dependent with maximal levels being reached after 8 h of culture (Fig.  3 ). Our data agree with previous findings showing that monocytes/ macrophages produced TNF-␣ shortly after stimulation with lipoproteins (38, 39) .
As PMA-differentiated THP-1 cells are resembling to tissue macrophages and are commonly used as models for human monocytes/macrophages (40), they were also tested for their ability to produce cytokines in presence of the bacterial components. As already observed with human monocytes/macrophages, inactivated EB as well as rMip were the most effective stimuli in triggering the synthesis of IL-1␤, TNF-␣, IL-6, and IL-8. Hsp60 triggered a lower but significant synthesis of IL-1␤, TNF-␣, IL-6, and IL-8. Hsp70 triggered a very low but significant synthesis of IL-6, and pgp3 and Chlamydia LPS stimulated a low IL-8 production, whereas E. coli and S. typhimurium LPS strongly stimulated the synthesis of all the cytokines (Fig. 4) . Because rMip was the only chlamydial Ag that consistently stimulated THP-1 cells, dose-response and time course experiments were performed with rMip. At concentrations ranging from 0.001 to 10 g/ml, rMip elicited a dose-dependent increase in IL-1␤, TNF-␣, and IL-8 production with maximal response at 10 g/ml. The production of cytokines was significantly stimulated when cells were incubated with 1 g/ml rMip (Fig. 5) . When comparing Figs. 2 and 5, the proinflammatory activity of rMip was weaker in PMA-differentiated THP-1 cells than in primary human monocytes/macrophages. This difference might be due to different levels of TLRs or CD14 expression at the surface of the cells. In PMA-differentiated THP-1 cells, significant stimulation of TNF-␣ release was already detected within 2 h and increased rapidly thereafter. At 24 h, TNF-␣ levels reached peak values and then declined gradually (Fig. 6) .
Because the response of human monocytes/macrophages varied from one donor to another, the proinflammatory activity of rMip was further studied on PMA-differentiated THP-1 cells to obtain more homogeneous and reproducible data. Based on above results and for practical reasons, the effect of rMip was further examined at 1 g/ml concentration and at the shortest time point (4 h) required to obtain a significant production of TNF-␣.
E. coli LPS contamination is not involved in the production of TNF-␣ mediated by rMip
Despite the fact that no endotoxin was detected by the Limulus Amoebocyte lysate assay in the highly purified preparation of rMip, the possibility that its proinflammatory activity could be attributed to E. coli LPS contamination was further investigated by testing rMip sensitivity to polymyxin B (50 g/ml). The ability of rMip to induce TNF-␣ production by PMA-differentiated THP-1 cells was unaffected by the presence of polymyxin B whereas highly purified E. coli LPS was unable to induce TNF-␣ production in presence of polymyxin B. In addition, rMip and LPS differed in their serum requirement: in absence of serum, TNF-␣ production induced by rMip was significantly increased whereas E. coli LPS was devoid of effect as already reported (41) (42) (43) (44) (Fig. 7) . observed a neutralization of the organism in cell culture in presence of anti-Mip Ab. To investigate whether the proinflammatory activity of C. trachomatis EB could be attributed to the presence of native Mip exposed at the EB surface (20) , experiments were conducted in presence and in absence of rabbit polyclonal IgG antirMip. The presence of 80 g/ml IgG anti-rMip led to significant inhibition of TNF-␣ release (33%, p ϭ 0.014) when compared with TNF-␣ release in presence of preimmune rabbit IgG (Fig. 8) . These results show that native Mip exposed at the EB surface contributes to induce TNF-␣ production when PMA-differentiated THP-1 cells are cultured in presence of C. trachomatis EB.
Anti-rMip polyclonal IgG partly inhibit the production of TNF-␣ mediated by C. trachomatis EB
Native Mip but not C20A rMip variant elicited proinflammatory cytokine production
To ascertain that wild-type (WT) rMip activity featured the same stimulatory properties than native Mip, this lipoprotein was purified from C. trachomatis EB by immunoprecipitation and tested for its ability to induce the production of TNF-␣ by PMA-differentiated THP-1 cells. In addition, to assess the importance of lipid modification, proinflammatory activity of nonlipidated C20A rMip variant was also tested. As shown in Fig. 9 , native Mip was able to induce release of TNF-␣ and IL-8, in a similar amount than WT rMip. In contrast, no cytokine production was observed when THP-1 cells were cultured in presence of C20A rMip variant suggesting that lipidation plays a major role in proinflammatory activity of native and WT rMip. 5 cells/1 ml per well) were cultured with 10 nM PMA for 48 h and then stimulated by rMip or E. coli LPS (1 g/ml) in the presence or absence of 50 g/ml polymyxin B sulfate, and in the presence or absence of 10% FBS. After 4 h stimulation, supernatants were collected and their content in TNF-␣ were analyzed by ELISA. Each value represents the mean Ϯ SD of triplicates from two experiments for polymyxin assay and from four experiments for FBS assay. ‫,ء‬ p Ͻ 0.05; ‫,ءءء‬ p Ͻ 0.0001 determined by comparison with medium alone using Student's t test.
Production of proinflammatory cytokines induced by rMip is lipid dependent
Because rMip appeared to have the same proinflammatory activity that native Mip and because it is not feasible to purify adequate amount of native Mip from C. trachomatis for analysis, WT rMip, previously shown to be lipidated as native Mip (20) , was used for further investigation. To determine the biochemical nature of rMip proinflammatory activity, experiments were conducted to examine the possible involvement of protein and lipid parts of rMip. To determine the importance of the total protein part, attempts to destroy rMip activity by heat, and proteinase K were tested. Heat treatment was unsuccessful, indicating that protein's native conformation is not essential for rMip stimulatory activity. Digestion with proteinase K resulted in loss of the 27.6-and 32-kDa bands (20) (data not shown) but did not affect proinflammatory activity. This result suggests that rMip activity may still reside in resulting lipopeptides after proteolytic digestion, as was already reported for a macrophage-activating lipopeptide from Mycoplasma fermentans (46) . The involvement of the lipopeptide moiety was confirmed by three different treatments releasing ester-linked fatty acids. Alkaline hydrolysis completely abolished rMip activity and treatment with lipases from two different sources led to significant losses of TNF-␣ release (76% with pig pancreas and 78% with R. arrhizus lipases, p Ͻ 0.05) (Fig. 10) . No significant difference was observed between untreated and mock-treated PMA-differentiated THP-1 cells (data not shown). The substitution of rMip with fatty acids in an ester linkage, alkali-labile (47), appears therefore to be crucial for its proinflammatory activity, as reported for other lipoproteins or lipopeptides (33, 48 -51). These data confirm that lipid modification of rMip is essential for its ability to stimulate production of proinflammatory cytokines by PMA-differentiated THP-1 cells.
CD14, TLR1, TLR2, and TLR6 but not TLR4 are involved in rMip activation of THP-1 cells
If rMip is able to induce proinflammatory cytokines in human monocytes/macrophages, the specific host receptors that mediate its activation is unknown. As TLRs and CD14 are usually involved in bacterial lipoprotein recognition (52) , experiments were conducted in the presence and in the absence of function-blocking mAbs against CD14, TLR1, TLR2, TLR4, and TLR6. These receptors are expressed on cell surface of both human monocytes and monocytic cell line THP-1 (29, 53, 54) . The pretreatment of THP-1 cells with MY4, an Ab blocking the mCD14-part of the LPS receptor (55), led to significant inhibition ( p Ͻ 0.05) of rMipmediated TNF-␣ production, indicating that rMip binds to mCD14 at the LPS-binding site as already observed for spirochaetal lipoproteins (53, 56, 57) . The pretreatment of THP-1 cells with TL2.1, a specific blocker of extracellular human TLR2 (58) or GD2.F4, a mAb blocking TLR1 (59), led to significant inhibitions ( p Ͻ 0.05) of rMip-mediated TNF-␣ production, whereas no significant effect was observed neither in presence of HTA125, an anti-TLR4 blocking mAb (60, 61) nor in presence of the clone 127, an anti-TLR6 blocking mAb (29) . The combination of anti-TLR2 with either anti-TLR6 or -CD14 led to clear inhibitions ( p Ͻ 0.005), and the combination of anti-TLR2 with anti-TLR1 to an almost complete inhibition ( p Ͻ 0.0001) of TNF-␣ secretion, as shown in Fig. 11A . When inactivated C. trachomatis EB were used as stimulant, the combination of anti-TLR2 with anti-CD14, anti-TLR1, or anti-TLR6 induced significant inhibitions ( p Ͻ 0.05 to 0.005), whereas the combination of anti-TLR4 with anti-CD14 provoked no significant reduction of EB-mediated TNF-␣ synthesis, as shown in Fig. 11B . Because TLR1 and TLR2 have been shown to be required for recognition of triacylated lipopeptides, such as Pam 3 CSK 4 (62-64) whereas TLR6 and TLR2 were required for recognition of diacylated lipopeptides such as Pam 2 CSK 4 but not for recognition of triacylated lipopeptides (63, 65) , these two prototypic synthetic lipopeptides were used as controls and tested in the same conditions. When Pam 3 CSK 4 was used as stimulant, the pretreatment of THP-1 cells with the combination but rather a tendency of Pam 3 CSK 4 to stimulate THP-1 cells more efficiently via TLR2/TLR1 and Pam 2 CSK 4 via TLR2/TLR6. Because E. coli LPS is commonly used as TLR4 and CD14-ligand (66) , it was also used as control and tested in the same conditions. The pretreatment of THP-1 cells with the combination of anti-TLR4 with anti-CD14 led to significant inhibitions of TNF-␣ secretion ( p Ͻ 0.005), whereas no inhibition was obtained with the combination of anti-TLR2 with anti-CD14, as shown in Fig. 12C . In all these experiments, no significant change of cytokine production was induced by nonimmune mouse IgG used as controls instead of each mAb. FIGURE 11. The production of TNF-␣ by PMA-differentiated THP-1 cells upon rMip or inactivated C. trachomatis EB activation is mainly TLR2/TLR1/TLR6/CD14 dependent. PMA-differentiated THP-1 cells were preincubated for 1 h with 50 g/ml human IgG to block Fc receptors and prevent nonspecific binding of blocking Ab or control IgG. Cells were next preincubated for 1 h at 37°C in the presence or absence of 5 g/ml of various blocking mAbs: anti-TLR1, anti-TLR2, anti-TLR4, anti-TLR6, anti-CD14, or isotype-matched mouse IgG1, IgG2a, and IgG2b controls alone or associated before addition of either 1 g/ml rMip (A) or inactivated C. trachomatis EB (5 ϫ 10 6 /ml) (B). Results were expressed as TNF-␣ concentrations obtained in each condition, included pretreatment of cells with isotype controls. Each value represents mean Ϯ SD of triplicates from one representative of two or three independent experiments with similar results. ‫,ء‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.005; ‫,ءءء‬ p Ͻ 0.0001 determined by comparison with control using Student's t test. 
CD14, TLR1, TLR2, and TLR6 are involved in rMip activation of HEK-293 cell lines expressing human TLR1/2, TLR2/6, or TLR2/CD14
To further ensure proper identification of receptors involved in the recognition of rMip and to assess their respective contribution, a cell model using HEK-293 cells transfected with human TLR1/2, TLR2/6, or TLR2/CD14 genes was used. Null cells lacking TLRs and CD14 responded to rMip by producing a 2.8-fold increase of IL-8 release in absence of stimulation, indicating that rMip was able to slightly stimulate these cells in absence of TLRs and CD14 but no response was observed with other stimulants. In contrast, HEK-293 cells expressing either hTLR1/2, or hTLR2/6, or hTLR2/CD14 responded to all stimulants, except E. coli LPS. The highest stimulatory effect of rMip was obtained under the condition of hTLR1/2 coexpression that led to a 26-fold higher release of IL-8 than in absence of stimulant ( p Ͻ 0.0001). The hTLR2/6 and hTLR2/CD14 coexpressions led to a 16-and 9-fold increase of IL-8 release ( p Ͻ 0.005), respectively. In presence of inactivated C. trachomatis EB, the highest stimulatory effect was also obtained under the condition of hTLR1/2 coexpression that led to a 6-fold higher release of IL-8 than in absence of stimulant ( p Ͻ 0.0001).
The hTLR2/6 and hTLR2/CD14 coexpressions led to a 3-and 5-fold increase of IL-8 release ( p Ͻ 0.05 to 0.005), respectively. These results agree with those obtained in blocking experiments. In presence of lipopeptides, the effects were dependent upon the stimulating concentrations. At 1 g/ml concentration, HEK-293 cells coexpressing hTLR1/2, hTLR2/6, or hTLR2/CD14 responded to both Pam 3 CSK 4 
Discussion
The present study demonstrates that among seven individual chlamydial components, rMip was the most effective to induce a proinflammatory cytokine response in human monocytes/macrophages (peripheral blood monocytes and THP-1 cell line). Even if rMip responses were lower than those induced by E. coli and S. typhimurium LPS, they were significant in contrast to Chlamydia LPS, as already reported (10, 15, 36, 71) . IL-8 was the dominant cytokine induced by rMip in vitro and this observation must be related to the cytokine patterns present in vivo during infection by chlamydiae where high levels of IL-8 were reported in tears from children with trachoma, as well as in endocervical secretions obtained from women infected with Chlamydia (72) .
The proinflammatory activity induced by WT rMip was not due to E. coli LPS contamination, as determined by the Limulus Amoebocyte lysate assay, insensitivity to polymyxin B, different serum requirement, and absence of inhibition by anti-TLR4 Abs. The stimulatory activities of WT rMip were similar to those of native Mip and appeared to be dependent upon lipid modification because nonlipidated C20A rMip variant was devoid of effect on cytokine release. In addition, WT rMip activity was greatly reduced by alkaline hydrolysis or treatment with lipases but was unaffected by heat or proteinase K treatments. The cell receptors involved in rMip and C. trachomatis EB cellular activation were determined using two independent assays that clearly demonstrated the involvement of TLR1/2/6 and CD14 but not TLR4. The main receptors involved in rMip activation were TLR1/2 but the co-presence of TLR1, TLR6, and CD14 was not absolutely required because activation was possible by TLR1/2, TLR2/6, or TLR2/ CD14. In these assays, the receptors involved in Pam 3 CSK 4 and Pam 2 CSK 4 activation did not completely agree with the original concept, according to which triacylated lipopeptides recognize TLR2/TLR1 heteromers, whereas diacylated lipopeptides recognize TLR2/TLR6 heteromers (63, 65, 73) but agree with other reports (68 -70) . Indeed, the ability of Pam 3 CSK 4 to stimulate HEK-293 cells coexpressing hTLR1/2 and, to a lesser extent, hTLR2/6 has been reported (68) and Pam 3 CSK 4 has been shown to exhibit some activity toward TLR2/6 when used at high concentrations (69). Pam 2 CSK 4 has been shown to exhibit comparable activities toward both the human TLR2/1 and TLR2/6 pairs (69) and macrophages of TLR6-deficient mice to be fully responsive to Pam 2 CSK 4 (70) . In fact the number of acyl-residues, the peptide sequence and the whole molecular structure of the lipopeptide/ lipoprotein have been shown to be responsible for TLR2/1-or TLR2/6-dependent signaling (70, 74) . The involvement of CD14 in rMip activation agrees with other studies showing that bacterial lipoproteins (53, 56, 57, 75, 76) , Pam 3 CSK 4 (53, 77) , and Pam 2 CSK 4 (68) interact with CD14 to cause cytokine induction. These results agree with reports showing a predominant role of TLR2 in C. trachomatis (78) as well as C. pneumoniae recognition (14, 19, 79) and with results of Netea et al. (14) attributing proinflammatory cytokine production to non-LPS components. The fact that rMip and EB act through the same receptors and that anti-rMip Ab is able to partly inhibit EB-mediated TNF-␣ release suggest a role of native Mip, present at the EB surface (20) , or other surface lipoproteins in EB recognition and macrophage activation in natural infection. If IL-1␤, TNF-␣, and IL-6 release in response to native Mip or other lipoproteins may aid in eradicating Chlamydia infection (80 -83) , particularly if their levels increase early (83) , these cytokines may also promote long-term tissue damage. As an example, high levels of TNF-␣ have been associated with detrimental effects in ocular chlamydial infection (84) . Moreover, Mipinduced IL-8 can be deleterious (83) , particularly in case of chronic secretion. Indeed, IL-8 promotes the infiltration of neutrophils that are not only inefficient in resolving chlamydial infections but can release proteases that damage cells. In addition and as reported for other bacterium-associated lipoproteins (85) , Mip or other lipoproteins could be released from EB surface (either from living bacteria or from bacteria lysed as a result of effective host defense or the activities of certain antibiotics) and retained inside tissues where they might activate resident cells and perpetuate inflammation even after the eradication of live bacteria with antibiotic therapy. Lipoproteins are considered as crucial virulence factors in inflammatory processes and in pathogenesis of several important bacterial infections, such as those triggered by Mycobacterium tuberculosis (76) , Neisseria gonorrhoeae (86) , Listeria monocytogenes (58, 87) , Brucella abortus (88) , and members of Enterobacteriaceae family (89, 90) . In organisms such as Borrelia burgdorferi and Treponema pallidum, which lack LPS, bacterial lipoproteins are known to play an important role in pathogenesis (49, 75, 88, (91) (92) (93) . In chlamydiae, LPS is a major structural component of all chlamydial species (22) but compared with the LPS of enterobacteria, it has much lower endotoxin activity (10, 71, 94, 95) because its lipid A is highly hydrophobic and has unique structural features with the presence of unusual, long-chain fatty acids (96) . Chlamydia LPS is unable to elicit inflammation in experimental animals (13) and is a weak inducer of the inflammatory cytokine response (10, 36, 37) , as shown in the present study. All these data support the hypothesis that in chlamydiae, Mip or other lipoproteins might play a key role in pathogenesis. The fact that Mip is present in the membrane of EBs as well as reticulate bodies (97) and was recently shown to be surface exposed by two different approaches (20) reinforces its potential role in pathogenesis of Chlamydia infection. If the exact chemical nature of Chlamydiaderived monocyte/macrophage stimulators is not known, the fact that receptors involved in Mip recognition are similar to those involved in C. trachomatis EB recognition is supportive of the involvement of Mip or other Chlamydia-associated lipoproteins as inflammatory active element of EB.
In conclusion, this study is the first report about a chlamydial lipoprotein displaying proinflammatory properties. As Mip appears to be present in different species of the Chlamydiaceae family (20) , it could have an important role in the inflammatory aspects of trachoma, reactive arthritis, or atherogenesis.
